Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
The AAPS Journal|March 19, 2020
Applying Beta Distribution in Analyzing Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath SharmaThe AAPS Journal|July 24, 2020
Facilitating Longitudinal Exposure-Response Modeling of a Composite Endpoint Using the Joint Modeling of Sparsely and Frequently Collected SubcomponentsChuanpu Hu, Honghui Zhou, Amarnath SharmaThe AAPS Journal|July 23, 2020
Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath SharmaJournal of Pharmacokinetics and Pharmacodynamics|June 22, 2017
Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patientsChuanpu Hu, Bruce Randazzo, Amarnath Sharma, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure-response modeling of Mayo scores for golimumab in patients with ulcerative colitisChuanpu Hu, Omoniyi J Adedokun, Liping Zhang, et al.Journal of Clinical Pharmacology|June 15, 2018
Exposure-Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid ArthritisYan Xu, Chuanpu Hu, Yanli Zhuang, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 20, 2021
Improving categorical endpoint longitudinal exposure-response modeling through the joint modeling with a related endpointChuanpu Hu, Honghui ZhouJournal of Clinical Pharmacology|May 21, 2008
An improved approach for confirmatory phase III population pharmacokinetic analysisChuanpu Hu, Honghui ZhouJournal of Pharmacokinetics and Pharmacodynamics|November 11, 2015
Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritisChuanpu Hu, Honghui ZhouJournal of Pharmacokinetics and Pharmacodynamics|March 18, 2018
A comprehensive evaluation of exposure-response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasisChuanpu Hu, Zhenling Yao, Yang Chen, et al.Pageof 19